• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

中国社区老年人肌少症的患病率：系统综述。

Prevalence of sarcopenia in Chinese community-dwelling elderly: a systematic review.

机构信息

School of Physical Education, Shandong University, 17922 Jingshi Road, Lixia District, Shandong Province, 250061, Jinan City, China.

School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, 44 West Wenhua Road, Lixia District, Shandong Province, 250102, Jinan City, China.

出版信息

BMC Public Health. 2022 Sep 8;22(1):1702. doi: 10.1186/s12889-022-13909-z.

DOI:10.1186/s12889-022-13909-z
PMID:36076194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9454186/
Abstract

BACKGROUND

Sarcopenia is associated with age-related loss of muscle mass and function and is becoming prevalent in the older Chinese population. This systematic review aims to obtain a reliable estimation of the prevalence of sarcopenia among community-dwelling Chinese populations aged 65 years and older and to characterize its epidemiology.

METHODS

A literature search was performed in the Cochrane Library, PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data, and CQVIP databases up to September 31, 2021. All studies that reported the prevalence of sarcopenia in Chinese community-dwelling older adults were included, and Hoy et al.'s tool was used to assess the risk of bias. The overall prevalence of sarcopenia will be calculated as the primary outcome, and subgroup analyses will be performed by study year, age, sex, muscle mass assessment method, diagnostic criteria and area.

RESULTS

A total of 26 studies were included in this study, which involved 25,921 subjects, and 3597 had sarcopenia. Although significant heterogeneity between studies was reported, no statistically significant publication bias was detected. The overall prevalence of sarcopenia in community-dwelling older adults aged over 65 years in the Chinese population was 17.4% (95% CI: 14.6%-20.2%). Subgroup analysis based on study year, age and sex, muscle mass assessment method, diagnostic criteria, region and area showed that the prevalence of sarcopenia was different in each subgroup.

IMPLICATIONS

The prevalence of sarcopenia in Chinese community-dwelling older adults was higher than that in previous studies. As a multidimensional survey of the prevalence of sarcopenia in older adults, this meta-analysis provides data support for the targeted management of sarcopenia among Chinese older adults.

摘要

背景

肌少症与年龄相关的肌肉质量和功能丧失有关，在中国老年人群中越来越普遍。本系统评价旨在获得可靠的估计，即 65 岁及以上社区居住的中国人群中肌少症的患病率，并描述其流行病学特征。

方法

我们在 Cochrane 图书馆、PubMed、Web of Science、中国国家知识基础设施（CNKI）、万方数据和 CQVIP 数据库中进行了文献检索，检索截至 2021 年 9 月 31 日。所有报告中国社区居住的老年人肌少症患病率的研究都被纳入，并且使用 Hoy 等人的工具评估了偏倚风险。总体肌少症患病率将作为主要结局进行计算，并将按研究年份、年龄、性别、肌肉质量评估方法、诊断标准和地区进行亚组分析。

结果

本研究共纳入 26 项研究，涉及 25921 名受试者，其中 3597 名患有肌少症。尽管报告了研究之间存在显著的异质性，但未检测到统计学上显著的发表偏倚。中国 65 岁及以上社区居住的老年人中肌少症的总体患病率为 17.4%（95%CI：14.6%-20.2%）。基于研究年份、年龄和性别、肌肉质量评估方法、诊断标准、地区和面积的亚组分析表明，肌少症的患病率在每个亚组中均不同。

结论

中国社区居住的老年人中肌少症的患病率高于以往研究。作为对老年人肌少症患病率的多维调查，本荟萃分析为中国老年人肌少症的针对性管理提供了数据支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/6c79c173f7fe/12889_2022_13909_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/1840b1443799/12889_2022_13909_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/36d12ffaa93b/12889_2022_13909_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/b901e3ec2978/12889_2022_13909_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/b7e07406b2b1/12889_2022_13909_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/de902d151002/12889_2022_13909_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/1d272df6b242/12889_2022_13909_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/659960552206/12889_2022_13909_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/7d1e76673170/12889_2022_13909_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/641247337773/12889_2022_13909_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/a975d811b300/12889_2022_13909_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/6c79c173f7fe/12889_2022_13909_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/1840b1443799/12889_2022_13909_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/36d12ffaa93b/12889_2022_13909_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/b901e3ec2978/12889_2022_13909_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/b7e07406b2b1/12889_2022_13909_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/de902d151002/12889_2022_13909_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/1d272df6b242/12889_2022_13909_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/659960552206/12889_2022_13909_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/7d1e76673170/12889_2022_13909_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/641247337773/12889_2022_13909_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/a975d811b300/12889_2022_13909_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e3/9454186/6c79c173f7fe/12889_2022_13909_Fig11_HTML.jpg

相似文献

1
Prevalence of sarcopenia in Chinese community-dwelling elderly: a systematic review.中国社区老年人肌少症的患病率：系统综述。
BMC Public Health. 2022 Sep 8;22(1):1702. doi: 10.1186/s12889-022-13909-z.
2
Prevalence of sarcopenia in older Chinese adults: a systematic review and meta-analysis.老年人肌少症的患病率：系统评价和荟萃分析。
BMJ Open. 2021 Aug 19;11(8):e041879. doi: 10.1136/bmjopen-2020-041879.
3
The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression.中国老年人肌少症患病率的 Meta 分析和 Meta 回归。
Nutrients. 2021 Apr 24;13(5):1441. doi: 10.3390/nu13051441.
4
Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.社区居住老年人肌少症的相关因素：系统评价和荟萃分析。
Nutrients. 2021 Nov 27;13(12):4291. doi: 10.3390/nu13124291.
5
Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis.社区居住、养老院和住院个体中肌少症患病率的差异。系统评价和荟萃分析。
J Nutr Health Aging. 2020;24(1):83-90. doi: 10.1007/s12603-019-1267-x.
6
Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents.修订的 EWGSOP 标准与其他四种肌少症诊断标准在中国社区居住的老年居民中的比较。
Exp Gerontol. 2020 Feb;130:110798. doi: 10.1016/j.exger.2019.110798. Epub 2019 Dec 6.
7
Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people.运用新型生物电阻抗分析技术评估中国社区老年人肌肉减少症的患病率
BMC Geriatr. 2016 Dec 28;16(1):216. doi: 10.1186/s12877-016-0386-z.
8
Falls among older adults with sarcopenia dwelling in nursing home or community: A meta-analysis.居住在养老院或社区的老年肌少症患者跌倒：一项荟萃分析。
Clin Nutr. 2020 Jan;39(1):33-39. doi: 10.1016/j.clnu.2019.01.002. Epub 2019 Jan 8.
9
The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis.中国老年人肌少症的患病率及其危险因素：系统评价和荟萃分析。
Front Public Health. 2024 Aug 5;12:1415398. doi: 10.3389/fpubh.2024.1415398. eCollection 2024.
10
Adherence to a standardized protocol for measuring grip strength and appropriate cut-off values in adults over 65 years with sarcopenia: a systematic review protocol.65岁以上患有肌肉减少症的成年人握力测量的标准化方案及适当临界值：一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):50-9. doi: 10.11124/jbisrir-2015-2256.

引用本文的文献

1
Prevalence of sarcopenia in patients with surgical obstructive jaundice and its impact on clinical outcomes.外科梗阻性黄疸患者中肌肉减少症的患病率及其对临床结局的影响。
World J Gastrointest Surg. 2025 Aug 27;17(8):107209. doi: 10.4240/wjgs.v17.i8.107209.
2
Prevention of Sarcopenia.预防肌肉减少症。
Adv Exp Med Biol. 2025;1478:365-405. doi: 10.1007/978-3-031-88361-3_15.
3
Dyrk1b as a potential biomarker for sarcopenia in older adults.酪蛋白激酶1家族成员1B（Dyrk1b）作为老年人肌肉减少症的潜在生物标志物。

本文引用的文献

1
Twelve-year sarcopenia trajectories in older adults: results from a population-based study.老年人十二年肌少症轨迹：一项基于人群的研究结果。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):254-263. doi: 10.1002/jcsm.12875. Epub 2021 Nov 30.
2
Prevalence of sarcopenia in older Chinese adults: a systematic review and meta-analysis.老年人肌少症的患病率：系统评价和荟萃分析。
BMJ Open. 2021 Aug 19;11(8):e041879. doi: 10.1136/bmjopen-2020-041879.
3
Preliminary screening for sarcopenia and related risk factors among the elderly.老年人肌少症及相关危险因素的初步筛查。
BMC Geriatr. 2025 Apr 25;25(1):278. doi: 10.1186/s12877-025-05942-5.
4
A predictive nomogram based on triglyceride glucose index to body mass index ratio for low appendicular skeletal muscle mass.基于甘油三酯葡萄糖指数与体重指数之比预测低骨骼肌质量的列线图。
Sci Rep. 2025 Apr 2;15(1):11366. doi: 10.1038/s41598-025-94823-3.
5
Effect of Resistance Training on Older Adults with Sarcopenic Obesity: A Comprehensive Systematic Review and Meta-Analysis of Blood Biomarkers, Functionality, and Body Composition.抗阻训练对患有肌少症肥胖的老年人的影响：对血液生物标志物、功能和身体成分的全面系统评价与荟萃分析
Nurs Rep. 2025 Mar 4;15(3):89. doi: 10.3390/nursrep15030089.
6
Association between dietary patterns and sarcopenia among community-dwelling older adults in five provinces of China: a cross-sectional study.中国五个省份社区居住老年人的饮食模式与肌肉减少症之间的关联：一项横断面研究
Front Public Health. 2025 Feb 28;13:1556033. doi: 10.3389/fpubh.2025.1556033. eCollection 2025.
7
Low serum HSPA12B levels are associated with an increased risk of sarcopenia in a Chinese population of older adults.低血清HSPA12B水平与中国老年人群肌肉减少症风险增加相关。
Cell Stress Chaperones. 2025 Mar;30(2):100-108. doi: 10.1016/j.cstres.2025.02.003. Epub 2025 Feb 19.
8
Prevalence and influencing factors of sarcopenia among older adults in rural coastal areas of Ningbo City.宁波市沿海农村地区老年人肌肉减少症的患病率及影响因素
Sci Rep. 2025 Feb 19;15(1):6037. doi: 10.1038/s41598-025-90017-z.
9
The Dietary Inflammatory Index and Sarcopenia in Older Adults in Four Chinese Provinces: A Cross-Sectional Study.中国四个省份老年人的饮食炎症指数与肌肉减少症：一项横断面研究
Nutrients. 2025 Jan 28;17(3):478. doi: 10.3390/nu17030478.
10
Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome-based therapeutic strategies.原发性肌肉减少症中的肠道菌群失调：潜在机制及对基于微生物群的新型治疗策略的启示
Front Microbiol. 2025 Jan 28;16:1526764. doi: 10.3389/fmicb.2025.1526764. eCollection 2025.
Medicine (Baltimore). 2021 May 14;100(19):e25946. doi: 10.1097/MD.0000000000025946.
4
[Association between dietary energy and protein intake and sarcopenia among the elderly in 8 cities across China].[中国8个城市老年人膳食能量和蛋白质摄入量与肌肉减少症的关联]
Wei Sheng Yan Jiu. 2021 Mar;50(2):242-255. doi: 10.19813/j.cnki.weishengyanjiu.2021.02.013.
5
Prevalence of Sarcopenia Among the Elderly in Korea: A Meta-Analysis.韩国老年人肌少症的患病率：一项荟萃分析。
J Prev Med Public Health. 2021 Mar;54(2):96-102. doi: 10.3961/jpmph.21.046. Epub 2021 Mar 4.
6
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.《PRISMA 2020声明：报告系统评价的更新指南》
Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4.
7
Estimation of sarcopenia prevalence in individuals at different ages from Zheijang province in China.估计中国浙江省不同年龄段人群肌少症的患病率。
Aging (Albany NY). 2021 Feb 18;13(4):6066-6075. doi: 10.18632/aging.202567.
8
Association between sarcopenia and cognitive impairment in community-dwelling population.社区居住人群中肌肉减少症与认知障碍之间的关联。
Chin Med J (Engl). 2020 Dec 7;134(6):725-727. doi: 10.1097/CM9.0000000000001310.
9
Decreased swallowing function in the sarcopenic elderly without clinical dysphagia: a cross-sectional study.肌少症老年人中无临床吞咽困难但吞咽功能下降：一项横断面研究。
BMC Geriatr. 2020 Oct 21;20(1):419. doi: 10.1186/s12877-020-01832-0.
10
Prevalence and Risk Factors Governing the Loss of Muscle Function in Elderly Sarcopenia Patients: A longitudinal Study in China with 4 Years of Follow-Up.中国一项为期 4 年的纵向研究：老龄化肌少症患者肌肉功能丧失的流行率及相关影响因素。
J Nutr Health Aging. 2020;24(5):518-524. doi: 10.1007/s12603-020-1361-0.